Phacoemulsification with intraocular lens implantation in cases of pars planitis
Phacoemulsification with intraocular lens implantation in cases of pars planitis
复制标题
DOI：
10.1016/j.jcrs.2004.02.090
复制
发表时间：
2004-10-01
影响因子：
2.8
通讯作者：
Biswas, J
中科院分区：
文献类型：
--
作者：
Ganesh, SK;Babu, K;Biswas, J
目的：目的分析晶状体超声乳化白内障手术联合植入不同生物材料的后房型人工晶状体（IOL）治疗睫状体平坦部炎的结果。86例患者的记录方法回顾性分析1997年1月~ 2003年4月行白内障超声乳化联合人工晶状体植入术的100例睫状体平坦部炎患者的临床资料。根据IOL生物材料将患眼分为3组：聚甲基丙烯酸甲酯（PMMA）（n = 32）、肝素表面改性PMMA（n = 39）或丙烯酸（n = 29）。结果：男47例，女39例。平均年龄为38岁（范围10 - 65岁），平均随访时间为19.67个月（范围3.00 - 54.53个月）。在最终随访时，91只眼（91%）的视力比术前更好; 79只眼改善了2行或更多Snellen线，12只眼改善了1行Snellen线，4只眼无变化，5只眼由于睫状体平坦部炎再激活和黄斑囊样水肿（CME）进展而视力下降。10只眼（10%）发生明显后囊膜混浊，50只眼（50%）发生CME，51只眼（51%）发生睫状体炎复发，29只眼（29%）发生IOL沉积，1只眼（1%）发生IOL偏心，14只眼（14%）发生前囊纤维化。视力恢复不良的最常见原因是CME、黄斑下纤维化和视网膜前膜。有没有统计学上的显着差异，这些并发症之间的3 groups.Conclusions：白内障超声乳化人工晶状体植入术在睫状体平坦部炎的眼睛是安全的，并导致在大多数情况下，良好的视觉效果。手术成功的因素是控制炎症、细致的手术、囊内人工晶状体植入和警惕的术后护理。(C)2004年ASCRS和ESCRS。
Purpose: To analyze the results of phacoemulsification cataract surgery with implantation of posterior chamber intraocular lenses (IOLs) of different biomaterials in eyes with pars planitis.Setting: Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.Methods: The records of 86 patients (100 eyes) with pars planitis who had phacoemulsification with IOL implantation between January 1997 and April 2003 were retrospectively analyzed. The eyes were divided into 3 groups depending on IOL biomaterial: poly(methyl methacrylate) (PMMA) (n = 32), heparin-surface-modified PMMA (n = 39), or acrylic (n = 29). The postoperative visual outcome and complications in each group were analyzed.Results: Forty-seven patients were men and 39, women. The mean age was 38 years (range 10 to 65 years) and the mean follow-up, 19.67 months (range 3.00 to 54.53 months). At the final follow-up, 91 eyes (91%) had better visual acuity than preoperatively; 79 had an improvement of 2 or more Snellen lines, 12 had an improvement of 1 Snellen line, 4 had no change, and 5 had a decrease as a result of reactivation of the pars planitis and progression of cystoid macular edema (CME). Significant posterior capsule opacification occurred in 10 eyes (10%), CME in 50 eyes (50%), reactivation of pars planitis in 51 eyes (51%), IOL deposits in 29 eyes (29%), IOL decentration in 1 eye (1%), and anterior capsule fibrosis in 14 eyes (14%). The most frequent cause of poor visual recovery was CME, submacular fibrosis, and epiretinal membrane. There was no statistically significant difference in these complications between the 3 groups.Conclusions: Phacoemulsification with IOL implantation in eyes with pars planitis was safe and led to good visual outcomes in most cases. The factors in surgical success were control of inflammation, meticulous surgery, in-the-bag IOL implantation, and vigilant postoperative care. (C) 2004 ASCRS and ESCRS.